Recently, cryoablation devices have emerged as a reliable and minimally invasive treatment option for early-stage RCC. This innovative technique is recognized as a safe and effective way for curing small kidney lesions. According to preliminary findings from a clinical trial, cryoablation device shows oncological outcomes comparable to surgery, with fewer complications and shorter hospital stays.
From the aspect of efficacy, cryoablation device has shown results with similar effectiveness, including similar rates of local recurrence-free survival and metastasis-free survival. This method is particularly beneficial for patients with multiple comorbidities and technically complex lesions, who may not be suitable for surgery.
Both ways are reliable options for patients opting for thermal ablation. Radiofrequency ablation uses a heat-based technique that utilizes an interstitial electrode to apply alternating electric current to the target tissue, resulting in coagulative tissue necrosis through the generation of heat from low-frequency radio-waves. Compared to RFA, cryoablation device tends to require fewer retreatments, offers enhanced local tumor control, and may entail a lower risk of metastatic progression.
More and more evidence shows that cryoablation device is helpful to the treatment of kidney cancer. In short, for patients who meet certain requirements, cryoablation device is supposed to be a safe and quick way of treating kidney cancer.
Hygea Medical Technology Co., Ltd. has significant advantages in the field of cryoablation device, which brings unprecedented innovation to the medical industry. With its outstanding performance, Hygea's cryoablation device has gained the trust and praise of numerous doctors and patients. Not only can it accurately target tissues in a very short time, achieving rapid and effective treatment, but it can also precisely control the freezing range to avoid unnecessary damage. What's more, Hygea places emphasis on the comfort and convenience of its products. Its cryoablation device is well-designed and easy to operate, enabling doctors to easily master its use and improve surgical efficiency. Moreover, the device features a user-friendly design, reducing patient discomfort during the procedure and enhancing the overall treatment experience.
In summary, Hygea's cryoablation device has become a leader in the medical device market with its unique technological advantages, precise treatment effects, and humanized design. They are committed to providing high-quality, safe, and efficient medical services for doctors and patients alike, driving progress and development in the medical field.
Hygea Medical Technology Co., Ltd.
Hygea Medical Technology Co., Ltd.
EN 
